startups digital health weight loss glp-1 Why Drugs Alone Aren't Enough for Sustainable – STAAR LABS Growth of GLP-1 Market: Weight

In MS research, tolerogenic peptide approaches targeting myelin basic protein have shown early promise

Originally discovered in human gastric juice, this peptide acts as a foundational signaling molecule for mucosal protection and internal balance (homeostasis)

Our team of experienced professionals will evaluate your medical history, lifestyle, and weight loss goals to create a plan tailored specifically for you

DY also received consulting or speaker fees from Sumitomo Dainippon Pharma, Boehringer Ingelheim, Astellas Pharma, MSD, Novo Nordisk, Ono Pharmaceutical, Eli Lilly, and Takeda Pharmaceutical

NEFA, Non-esterified fatty acids